Advances in diagnosing Creutzfeldt-Jacob disease with MRI and CSF 14-3-3 protein analysis

Neurology

Volumn 63, Issue 3, 2004, Pages 410-411

  Zeidler, Martin ^a   Green, Alison ^b  

^a VICTORIA HOSPITAL   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN 14 3 3; PROTEIN S 100; TAU PROTEIN;

BLOOD ANALYSIS; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EDITORIAL; ELECTROENCEPHALOGRAM; HUMAN; LIVER FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 3543061153     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000137379.68184.64     Document Type: Editorial

References (12)

1. Jones DP, Nevin S. Rapidly progressive cerebral degeneration (subacute vascular encephalopathy) with mental disorder, focal disturbance, and myoclonic epilepsy. J Neurol Neurosurg Psychiatry 1954;17:148-159.
2. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811-815.
3. Report of the WHO consultation on the global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. Geneva: WHO, 1998.
4. Collie DA, Sellar RJ, Zeidler M, Colchester ACF, Knight R, Will RG. MRI in Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 2001;56:726-739.
5. Gertz HJ, Henkes H, Cervos-Navarro J. Creutzfeldt-Jakob disease: correlation of MRI and neuropathologic findings. Neurology 1988;38:1481-1482.
6. Schröter A, Zerr I, Henkel K, Tschampa HJ, Finkenstaedt M, Poser S. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000;57:1751-1757.
7. Mao-Draayer Y, Braff SP, Nagle KJ, Pendlebury W, Penar PL, Shapiro RE. Emerging patterns of diffusion-weighted MR imaging in Creutzfeldt-Jakob disease: case report and review of the literature. AJNR Am J Neuroradiol 2002;23:550-556.
8. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443-449.
9. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-233.
10. Castellani R, Colucci M, Xie Z, et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004;63:436-442.
11. Zerr I, Schulz-Schaeffer WJ, Giese A, et al. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 2000;48:323-329.
12. Meissner B, Kohler K, Kortner K, et al. Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology 2004;63:450-456.